Skip to main content
Journal cover image

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Publication ,  Journal Article
Luterbach, CL; Boshe, A; Henderson, HI; Cober, E; Richter, SS; Salata, RA; Kalayjian, RC; Watkins, RR; Hujer, AM; Hujer, KM; Rudin, SD; Doi, Y ...
Published in: Open Forum Infect Dis
January 2019

In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMP-SMX. Development of resistance further limits the use of TMP-SMX in CRE infections.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

January 2019

Volume

6

Issue

1

Start / End Page

ofy351

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luterbach, C. L., Boshe, A., Henderson, H. I., Cober, E., Richter, S. S., Salata, R. A., … van Duin, D. (2019). The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis, 6(1), ofy351. https://doi.org/10.1093/ofid/ofy351
Luterbach, Courtney L., Ashley Boshe, Heather I. Henderson, Eric Cober, Sandra S. Richter, Robert A. Salata, Robert C. Kalayjian, et al. “The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.Open Forum Infect Dis 6, no. 1 (January 2019): ofy351. https://doi.org/10.1093/ofid/ofy351.
Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, et al. The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis. 2019 Jan;6(1):ofy351.
Luterbach, Courtney L., et al. “The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.Open Forum Infect Dis, vol. 6, no. 1, Jan. 2019, p. ofy351. Pubmed, doi:10.1093/ofid/ofy351.
Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin D. The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis. 2019 Jan;6(1):ofy351.
Journal cover image

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

January 2019

Volume

6

Issue

1

Start / End Page

ofy351

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences